Showing results (71-80 of 433) with videos related to
Sort By:
Pageof 44
JCO Oncology Practice|April 7, 2021
Non-Small-Cell Lung Cancer: Real-World Cost Consequence AnalysisAlessandra Buja, Giulia Pasello, Giuseppe De Luca, et al.Annals of Translational Medicine|July 19, 2016
Superior sulcus tumors (Pancoast tumors)Giuseppe Marulli, Lucia Battistella, Marco Mammana, et al.Transplantation|February 23, 2016
Cytomegalovirus Hyper Immunoglobulin for CMV Prophylaxis in Thoracic TransplantationFederico Rea, Luciano Potena, Nizar Yonan, et al.American Journal of Hypertension|May 26, 2021
Adherence to Treatment by Initial Antihypertensive Mono and Combination TherapiesFederico Rea, Laura Savaré, Matteo Franchi, et al.Clinical Transplantation|January 30, 2024
Human tracheal transplantation: A systematic review of case reportsVincenzo Verzeletti, Marco Mammana, Giovanni Zambello, et al.Advances in Therapy|June 21, 2018
Use of Nimesulide During Early Pregnancy and the Risk of Congenital Malformations: A Population-Based Study from ItalyAnna Cantarutti, Matteo Franchi, Federico Rea, et al.Journal of Hypertension|November 30, 2016
Blood pressure control in hypertension. Pros and cons of available treatment strategiesGiuseppe Mancia, Federico Rea, Cesare Cuspidi, et al.Journal of Clinical Epidemiology|September 1, 2019
A new population-based risk stratification tool was developed and validated for predicting mortality, hospital admissions, and health care costsFederico Rea, Giovanni Corrao, Monica Ludergnani, et al.Blood Pressure|September 23, 2022
The impact of renal denervation procedure on use of antihypertensive drugs in the real-life settingFederico Rea, Gabriella Morabito, Laura Savaré, et al.Diabetes Research and Clinical Practice|September 6, 2021
Comparing medication persistence among patients with type 2 diabetes using sodium-glucose cotransporter 2 inhibitors or glucagon-like peptide-1 receptor agonists in real-world settingFederico Rea, Stefano Ciardullo, Laura Savaré, et al.Pageof 44